# Ozempic / GLP-1 Litigation — safety & injury context

> Clinical summary and reported injury patterns. Not medical advice.

**Canonical URL:** https://drugsmonitor.com/drug-info/ozempic-glp-1-lawsuit
**Related case:** https://drugsmonitor.com/case/ozempic-glp-1-lawsuit
**Last updated:** 2026-06-11

## Clinical context

GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) are alleged to cause severe gastroparesis, obstruction, gallbladder disease, and pancreatitis in some users.

## Litigation context

MDL No. 3094 in the Eastern District of Pennsylvania; discovery and bellwether planning active into 2026.

---

*Discuss symptoms and treatment with a licensed clinician.*